Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101805380B details a scalable acetylation method for nucleoside intermediates, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN102701921B reveals a novel one-step synthesis for high-purity discotic liquid crystal intermediates, offering significant cost reduction and supply chain reliability for electronic chemical manufacturing.
Patent CN101553477A reveals a novel route for L-gluconic acid production, offering cost reduction in API manufacturing through improved yields and shorter reaction times.
Patent CN111377986B details a novel purification method for decitabine intermediate II, removing critical impurities to enhance beta-configuration yield and supply reliability.
Novel Pd-catalyzed method offers high yield and enantioselectivity for chiral intermediates. Reduces costs and simplifies supply chain for pharmaceutical manufacturing partners globally.
Novel method for trabectedin intermediate 2 using L-tyrosine. High chiral purity, mild conditions, scalable for API manufacturing.
Patent CN107522743A enables high-purity TAF synthesis. Enhances supply chain reliability and reduces manufacturing costs for antiviral intermediates.
Advanced stereocontrolled synthesis of trans-5-chloro-2-methyl-dibenzo-oxepino-pyrrole intermediates. Enhancing yield and purity for global pharmaceutical supply chains.
Solve low-yield challenges in alpha-vinyl azide production. This patent-validated method offers 80%+ yield, broad substrate scope, and scalable manufacturing for pharma R&D and procurement teams.
Solve regioselectivity challenges in carboxylic acid synthesis with 96% yield. NINGBO INNO PHARMCHEM offers scalable, cost-effective production for your API development.
Solve supply chain risks with air-stable, metal-free synthesis of trifluoroacetimide dihydrobenzofuran. High stereoselectivity, low cost, and scalable to 100MT/yr.
Discover a scalable, high-ee synthesis method for axial chiral indolopyrrole-furan compounds with proven cytotoxic activity against PC-3 cancer cells. Reduce production costs and supply chain risks with our CDMO expertise.
Solve supply chain risks with air-atmosphere, metal-free synthesis of trifluoroacetimide-substituted dihydrobenzofuran. High stereoselectivity, low-cost raw materials, and scalable to gram level for pharma R&D and production.
Solve supply chain risks with this ruthenium-catalyzed dihydrophenanthridine synthesis. Achieve 60-65% yields at mild conditions. Reduce production costs by 30%.
Solve low enantioselectivity & high cost in chiral indole synthesis. This patent's mild, scalable method delivers >90% ee & 98% yield for anti-tumor drug intermediates. Request COA now.
Solve harsh reaction conditions and poor functional group tolerance in trifluoromethyl heterocycle synthesis. Our CDMO expertise ensures scalable, high-purity production for pharma intermediates.
Eliminate high-pressure hydrogenation and resolution steps in Moxifloxacin side chain production. Achieve 99%+ ee and 20-30% yield with simplified process. Reduce costs and supply chain risks for API manufacturing.
Discover a novel synthesis method for indole-derived piperidines with >95% diastereoselectivity and 76% yield. Ideal for pharmaceutical R&D and cost-effective production of anti-cancer agents.
Solve nitroalkene synthesis challenges: mild conditions, 99% yield, E-selectivity. Reduce costs & waste with this scalable method.
Discover how biocatalytic synthesis of chiral pseudonucleosides offers superior enantioselectivity, reduced waste, and cost-effective production for your antiviral and antitumor drug development.